Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
5
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
5
×
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
5
×
national blog main
national top stories
5
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
5
×
wisconsin blog main
wisconsin top stories
boston top stories
eli lilly
ipo
abbvie
amgen
cancer
glaxosmithkline
startups
astrazeneca
biogen
black diamond therapeutics
What
bio
roundup
drugs
black
companies
diamond’s
fda
won
acquisitions
announced
appetite
approval
arguments
august
big
biotech
bread
busy
butter
buyout
cancer
cash
ceo
class
collabs
commercialized
competitors
continue
covid
daniel
days
deal
debut
decades
decisions
devices
diabetes
diamond
drug
eli
Language
unset
Current search:
allergan
×
national
×
" texas top stories "
×
" national top stories "
×
" clinical trials "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More